Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them
US8084580B2 · kind B2 · utility
3Cited by
6References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2007 |
| Grant date | Dec 27, 2011 |
| Priority date | — |
| Expiry date | Nov 3, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention discloses a purified albumin solution of human origin with low prekallicrein activator (PKA) activity and stability over time characterized in that it has an antithrombin content equal to or greater than 0.03 mg/g of albumin, and a process for production thereof by the partial extraction of the antithrombin during fractionation of the human plasma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.